Real-world results:
55% AKI reduction
Cath lab quality improvement programs to reduce AKI demonstrated a 55% mean relative AKI reduction with the DyeVert System.1-4
Comparative results:
51% AKI reduction
Studies comparing AKI rates in patients treated with and without the DyeVert System demonstrated a 51% mean relative AKI reduction in patients treated with DyeVert.5-8
By minimizing excess reflux, the DyeVert System reduces contrast delivered to patients without compromising image quality.
Reduced contrast volume leads to decreased reflux
Unnecessary contrast volume leads to excess reflux
The DyeVert System uses Bluetooth technology to accurately show how much contrast is delivered to a patient during a procedure.
Cumulative contrast volume delivered to patient
per injection contrast volume to patient
Contrast level remaining until threshold max is reached
Physician-specified threshold volume max
Percent contrast saved per injection
© 2021 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered Trademarks of Osprey Medical, Inc. in the United States and other countries.
